Logo for Elicio Therapeutics Inc

Elicio Therapeutics Investor Relations Material

Latest events

Logo for Elicio Therapeutics Inc

Status Update

Elicio Therapeutics
Logo for Elicio Therapeutics

Status Update

25 Jun, 2025
Logo for Elicio Therapeutics

Q1 2025

13 May, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies

Latest reports from Elicio Therapeutics Inc

Access all reports
Elicio Therapeutics Inc. is a biotechnology company focused on developing immunotherapies for the treatment of cancer and infectious diseases. The company specializes in AMP (Amphiphile) platform technology, designed to enhance the delivery of cancer vaccines and immunomodulators to the lymphatic system, improving immune response. The company is headquartered in Boston, Massachusetts, and its shares are listed on the NASDAQ.